Non-small-cell lung cancers

news

Activating c-Cbl gene causes immune system to attack cancer cells

3 January 2020 | By Hannah Balfour (Drug Target Review)

Upregulation of the c-Cbl gene causes degradation of the immune checkpoint protein PD-1 and may provide a possible new avenue for cancer therapies, according to researchers.

news

Reducing NOVA1 helps prevent tumour growth in lung cancer

8 August 2018 | By Dr Zara Kassam (Drug Target Review)

Researchers have identified a gene that when inhibited, reduced human non-small cell lung cancer tumours from growing...

news

NRF2 pathway provides new approach to cancer drug discovery

2 October 2017 | By Dr Zara Kassam (Drug Target Review)

Scientists have developed a promising new strategy for the discovery of novel anti-cancer therapies for non-small-cell lung cancers...